Novo Nordisk Presents New Wegovy Data for MASH
Novo Nordisk is presenting new study data on Wegovy for MASH, a liver disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.